HJR 33: Relating to requesting that the United States Food and Drug Administration or the United States Congress remove OxyContin from the market.
00 HOUSE JOINT RESOLUTION NO. 33 01 Relating to requesting that the United States Food and Drug Administration or the 02 United States Congress remove OxyContin from the market. 03 BE IT RESOLVED BY THE LEGISLATURE OF THE STATE OF ALASKA: 04 WHEREAS OxyContin is a controlled substance that contains oxycodone, 05 specifically oxycodone HCL controlled release; and 06 WHEREAS oxycodone is an opioid agonist with an addiction potential similar to that 07 of morphine; and 08 WHEREAS oxycodone is regulated under Alaska law (AS 11.71.140(b)(1)(N)) as a 09 Schedule IA controlled substance having "the highest degree of danger or probable danger to 10 a person or the public"; and 11 WHEREAS oxycodone is regulated under federal law as a Schedule II controlled 12 substance, which provides the highest level of control possible for approved drug products; 13 and 14 WHEREAS oxycodone, like morphine, has a high potential for abuse; it is supplied in 15 a controlled-release dosage form and is intended to provide up to 12 hours of relief from 16 moderate to severe pain; and
01 WHEREAS the oxycodone tablet must be taken whole and only by mouth; and 02 WHEREAS, when the oxycodone tablet is crushed and its contents are injected 03 intravenously or snorted into the nostrils, the controlled release mechanism is defeated, and a 04 potentially lethal dose of oxycodone is released immediately; and 05 WHEREAS, since 2001, there have been numerous reports of OxyContin diversion 06 from legitimate use and abuse across the United States, including Alaska; and 07 WHEREAS some of these reports of diversion and abuse have resulted in serious 08 consequences, including death; and 09 WHEREAS the United States Food and Drug Administration has reacted to these 10 reports by increasing the warnings that are supplied with the drug and providing information 11 to physicians concerning the proper use of OxyContin; and 12 WHEREAS the diversion and abuse of OxyContin has not decreased, and deaths 13 continue to result from OxyContin; and 14 WHEREAS the Alaska State Legislature believes that removal of oxycodone, and 15 thereby OxyContin, from the market is in the public interest, regardless of whether that 16 removal is accomplished by the United States Food and Drug Administration or the United 17 States Congress; 18 BE IT RESOLVED that the Alaska State Legislature respectfully requests that the 19 United States Food and Drug Administration remove oxycodone, and thereby OxyContin, 20 from the market; and be it 21 FURTHER RESOLVED that the Alaska State Legislature respectfully requests that 22 the United States Congress remove oxycodone, and thereby OxyContin, from the market if 23 the United States Food and Drug Administration does not. 24 COPIES of this resolution shall be sent to the Honorable George W. Bush, President 25 of the United States; the Honorable Mark B. McClellan, Commissioner of Food and Drugs, 26 U.S. Food and Drug Administration, U.S. Department of Health and Human Services; the 27 Honorable Ted Stevens, President Pro Tempore of the U.S. Senate and member of the Alaska 28 delegation in Congress; the Honorable J. Dennis Hastert, Speaker of the U.S. House of 29 Representatives; the Honorable Bill Frist, Majority Leader of the U.S. Senate; the Honorable 30 Tom DeLay, Majority Leader of the U.S. House of Representatives; the Honorable Thomas 31 Daschle, Minority Leader of the U.S. Senate; the Honorable Nancy Pelosi, Minority Leader of
01 the U.S. House of Representatives; the governors of each of the other 49 states; and to the 02 Honorable Lisa Murkowski, U.S. Senator, and the Honorable Don Young, U.S. 03 Representative, members of the Alaska delegation in Congress.